Evaluating TBK1 as a therapeutic target in cancers with activated IRF3
Muvaffak, Asli, Pan, Qi, Yan, Haiyan, Fernandez, Rafael, Lim, Jongwon, Dolinski, Brian, Nguyen, Thi T, Strack, Peter, Wu, Stephen, Chung, Rossana, Zhang, Weiqun, Hulton, Chris, Ripley, Steven, Hirsch, Heather, Nagashima, Kumiko, Wong, Kwok-Kin, Jánne, Pasi A, Seidel-Dugan, Cynthia, Zawel, Leigh, Kirschmeier, Paul T, Middleton, Richard E, Morris, Erick J, Wang, Yan
Published in Molecular cancer research (01.07.2014)
Published in Molecular cancer research (01.07.2014)
Get full text
Journal Article
Abstract 4372: Evaluating TBK1 as a cancer therapeutic target in cancer cell lines with activated IRF3
Muvaffak, Asli, Pan, Qi, Middleton, Richard, Morris, Erick, Fernandez, Rafael, Lim, Jonwong, Dolinski, Brian, Nguyen, Thi T., Strack, Peter, Yan, Haiyan, Chung, Rossana, Wu, Stephen, Zhang, Weiqun, Hulton, Chris, Hirsch, Heather, Nagashimo, Kumiko, Wang, Yan
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article